Document:

EX-10.11

 THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED 

INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) 

NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE 

COMPANY IF PUBLICLY DISCLOSED 
  

Exhibit 10.11 
 THE
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 
 AND 

IMMATICS US, INC. 
  

AMENDMENT NUMBER 1 – FACILITIES/EQUIPMENT USE AND SERVICES AGREEMENT 

This Amendment Number 1 (“Amendment”) to the Facilities/Equipment Use and Services Agreement (“Agreement”) is entered into
effective the 1st day of September 2015, by and between The University of Texas Health Science Center at Houston, (“UTHealth”) and Immatics US, Inc. (“Immatics”). UTHealth and
Immatics shall be known collectively as “the Parties” and singularly as “a Party” or “the Party.” 
 WHEREAS,
the Parties previously entered into an Agreement effective September 1, 2015, whereby UTHealth makes available certain facilities, equipment, and personnel in support of projects; and 

WHEREAS, the Parties now desire to amend the Agreement. 

NOW, THEREFORE, the Parties agree as follows: 
  

	1.	 Section 1.1.a shall be deleted in its entirety and replaced with the following: 

“Production Suites/Administrative Space. An exclusive license to use certain production suites and administrative space located in
the Facility, described as Rooms BBS 6312, BBS 6314, and a cubicle in BBS 6102 (the “Premises”). The use of Room BBS 6312 shall be for the period September 1, 2015 through December 31, 2017 and the use of Room BBS 6314 shall be
for the period February 1, 2016 through December 31, 2018.” 
  

	2.	 Section 9, bullet 2 shall be deleted in its entirety and replaced with the following:

 “● a base monthly fee of [***] per production suite (i.e., BBS 6312 and/or 6314) calculated in accordance
with the budget set forth in Exhibit E-2 for the applicable term set forth in section 1.1.a;” 

Except as provided for herein, all other terms and conditions of the Agreement effective September 1, 2015, shall remain in full force
and effect. 
 IN WITNESS WHEREOF, the Parties have executed this Amendment to be effective as of the first date written above. 

 

					
	SIGNED:	 		 	
			
	IMMATICS US, INC>	 		 	THE UNIVERSITY OF TEXAS HEALTH
		 		 	SCIENCE AT HOUSTON
			
	By: /s/ Steffen Walter                                	 		 	By: /s/ T. Kevin
Dillon                                
	 Steffen Walter
 Chief Scientific
Officer
	 		 	 T. Kevin Dillon
 Sr. Executive Vice President,
Chief Operating
 and Financial Officer

			
	Date:
2/1/2016                                        
   	 		 	Date:
2-1-2016EX-10.12

 THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED 

INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) 

NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE 

COMPANY IF PUBLICLY DISCLOSED 
  

Exhibit 10.12 
 Confidential 

THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 

AND 
 IMMATICS US, INC.

  
 AMENDMENT NUMBER 2
— FACILITIES/EQUIPMENT USE AND SERVICES AGREEMENT 
 This Amendment Number 2 (“Amendment”) to the Facilities/Equipment
Use and Services Agreement effective September 1, 2015 by and between The University of Texas Health Science Center at Houston, (“UTHealth”) and lmmatics US, Inc. (“lmmatics”), as amended (“Agreement”) is entered
into effective the 101h day of August 2016,. UTHealth and Immatics shall be known collectively as “the Parties” and singularly as “a Party” or “the Party.” 

WHEREAS, the Parties previously entered into the Agreement, whereby UTHealth makes available certain facilities, equipment, and personnel in
support of projects; and 
 WHEREAS, the Parties now desire to amend the Agreement. 

NOW, THEREFORE, the Parties agree as follows: 
  

	1.	 Section 1.1.a shall be deleted in its entirety and replaced with the following. 

“Production Suites/Administrative Space. An exclusive license to use certain production suites and administrative space located in
the Facility, described as Rooms BBS 6310, BBS 6312, BBS 6314, and a cubicle in BBS 6102 (the “Premises”). The use of BBS 6310 shall be for the period December 1, 2016 through December 31, 2017, BBS 6312 shall be for the period
September 1, 2015 through December 31, 2017 and the use of Room BBS 6314 shall be for the period February 1, 2016 through December 31, 2018. Immatics understands and acknowledges that the beginning date associated with BBS 6310
is a tentative date and is contingent upon UTHealth’s buildout and full operational access to the Judith R. Hoffberger laboratory located in UTHealth’s McGovern Medical School Building. 

UTHealth hereby grants to Immatics the option to, by written notice: (a) shorten the term of use for Room BBS 6310 set forth in
Section 1.1.a. of the Agreement, provided that the term will in no event end sooner than June 30, 2017 unless otherwise agreed in writing by the Parties, or (b) extend the term of use for Room BBS 6310 set forth in Section 1.1.a.
of the Agreement, provided that the term will in no event extend beyond June 30, 2018 unless otherwise agreed in writing by the Parties. Such shortened or extended term shall remain subject to all other terms and conditions of the
Agreement.” 
  

	2.	 Section 9, bullet 2 shall be deleted in its entirety and replaced with the following:

 “- a base monthly fee of [***] per production suite (i.e., BBS 6310, BBS 6312, and BBS 6314) calculated in
accordance with the budget set forth in Exhibit E-2 for the applicable term set forth in section 1.1.a. 

The Parties agree to renegotiate in good faith the base monthly cost and the per-patient costs set
forth in Exhibit E-2 and Exhibit E-3 on or before September 30, 2016. In the event the Parties fail to reach agreement on such updated costs by
September 30, 2016, UTHealth shall begin invoicing lmmatics, on a monthly basis, for the actual, documented base monthly and per-patient costs incurred by UTHealth under this Agreement for the items set
forth in Exhibit E-2 and Exhibit E-3, respectively.” 

 THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED 

INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) 

NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE 

COMPANY IF PUBLICLY DISCLOSED 
  

	3	 Immatics shall pay UTHealth a one-time comprehensive fee in accordance
with the following budget: 

  

													
	 One Time Comprehensive Cost
	  

	 Item
	  	Cost	 	  	Unit Used	 	  	Total	 
	 Exclusive access to Griffin facility for the period December 1, 2016 through
December 31, 2017
	  	 	[***]	 	  	 	[***]	 	  	 	[***]	 
		  				  	 	[***]	 	  	 	[***]	 
		  				  	  
	  
	 	  	  
	  
	 
		  				  	 	Grand Total	 	  	 	[***]	 
		  				  	  
	  
	 	  	  
	  
	 

 Except as provided for herein, all other terms and conditions of the Agreement shall remain in full force and
effect. 
 IN WITNESS WHEREOF, the Parties have executed this Amendment to be effective as of August 10th, 2016. 

SIGNED: 
  

			
	IMMATICS US, INC.	  	THE UNIVERSITY OF TEXAS HEALTH SCIENCE AT HOUSTON
		
	 By: /s/ Steffen
Walter                                        
        
 Steffen Walter

Chief Scientific Officer
	  	 By: /s/ T. Kevin
Dillon                                        

 T. Kevin Dillon
 Sr. Executive Vice President, Chief
Operating
 and Financial Officer

		
	Date:
8/16/2016                                        
                 	  	Date:
8/23/16EX-10.13

 THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED 

INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) 

NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE 

COMPANY IF PUBLICLY DISCLOSED 
  

Exhibit 10.13 
 THE
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 
 AND 

IMMATICS US, INC. 
  

AMENDMENT NUMBER 3 – FACILITIES/EQUIPMENT USE AND SERVICES AGREEMENT 

This Amendment Number 3 (“Amendment”) to the Facilities/Equipment Use and Services Agreement (“Agreement”) is entered into
effective the 1st day of October 2016, by and between The University of Texas Health Science Center at Houston, (“UTHealth”) and Immatics US, Inc. (“Immatics”). UTHealth and
Immatics shall be known collectively as “the Parties” and singularly as “a Party” or “the Party.” 
 WHEREAS,
the Parties previously entered into an Agreement effective September 1, 2015, as previously amended, whereby UTHealth makes available certain facilities, equipment, and personnel in support of projects; and 

WHEREAS, the Parties now desire to amend the Agreement. 

NOW, THEREFORE, the Parties agree as follows: 
  

	1.	 Section 3.3 shall be deleted in its entirety and replaced with the following: 

Consumable Supplies and Services. UTHealth shall make available the consumable supplies and services set forth in Exhibit D for use in
the Manufacturing Program. Process-specific reagents, supplies and services are not included in the cost set forth in Exhibit D. Unless prior approval is received by the Facility Director, all reagents, supplies and services not
included in Exhibit D shall be procured by UTHealth from vendors qualified by the Facility and invoiced separately. 
  

	2.	 Section 9, bullets 2, 3 and 4 shall be deleted in their entirety and replaced with the following:

 “●    a base monthly fee of [***] per production suite (i.e., BBS 6310, BBS 6312, and BBS
6314) calculated in accordance with the budget set forth in Exhibit E-2 for the applicable term set forth in section 1.1.a. 

●    a monthly minimum personnel fee of [***] in accordance with the budget set forth in Exhibit E-3. Any effort exceeding the values specified in exhibit E-3 will be documented and invoiced to Immatics on top of the minimum fee. 

●    a monthly fee of [***] for the exclusive use of a Biosafe Sepax 2 RM automated cell processing system for the
same term applicable to room BBS 6310 set forth in section 1.1.a. This fee includes maintenance of the instrument.” 
  

	3.	 Exhibit D shall be deleted in its entirety and replaced with the following: 

EXHIBIT D 
 Consumables
and Services provided to Immatics by UTHealth 
 [***] 

Immatics will supply to UTHealth copies of all standard operating procedures used in the Licensed Facilities and Certificates of Analysis of reagents and raw
materials used in the Manufacturing Program. These documents will be reviewed by Facility’s quality team and will be added to the Facility’s Quality Management System upon approval. 

 

	4.	 Exhibit E2 shall be deleted in its entirety and replaced with the following: 

 THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED 

INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) 

NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE 

COMPANY IF PUBLICLY DISCLOSED 
  

			
	Base Monthly Cost per suite (E2)
	 [***]

	Sub Total	  	[***]
	F&A [***]	  	[***]
	Grand Total	  	[***]

  

	5.	 Exhibit E3 shall be deleted in its entirety and replaced with the following: 

 

			
	Monthly Minimum Personnel Cost (E3)
	 [***]

	Sub Total	  	[***]
	F&A [***]	  	[***]
	Grand Total	  	[***]

  

			
	 Individual extra-ordinary serviceswill be billed separately

based on actual usage at the following rates (F)

	 Cleaning (in excess of the cleaning of the entire facility that UTHealth will carry out 4 times per month):

 
 1 suite

Entire facility
	 	
[***]                  
                  

	 Environmental Monitoring (in excess of the EM of the entire facility that UTHealth will carry out once per month):

 
 1 Suite

3 Suites
 Entire facility
	 	
[***]                  
                  

	 Quality Control Testing:
  

[***]
	 	[***]                            
	 Courier Service:
  

1 trip
 1 trip after hours (5pm to 6am and weekends)
	 	
[***]                  
          

 Except as provided for herein, all other terms and conditions of the Agreement effective September 1,
2015, as previously amended, shall remain in full force and effect. 
 IN WITNESS WHEREOF, the Parties have executed this Amendment to be effective as of
the first date written above. 

							
	SIGNED:	 		 		 	
				
	IMMATICS US, INC.	 		 	THE UNIVERSITY OF TEXAS HEALTH	 	
		 		 	SCIENCE AT HOUSTON	 	
				
	By: /s/ Harpreet Singh                                	 		 	By: T. Kevin
Dillon                                    	 	
	 Harpreet Singh
 CEO
	 		 	 T. Kevin Dillon
 Sr. Executive Vice President,
Chief Operating
 and Financial Officer
	 	
				
	Date: December 15, 2016                           	 		 	Date: 12/16/16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]